NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000077

Registered date:01/01/2006

Role of Thymidine Phosphorylase(TP), Dihydropyrimidine Dehydrogenase(DPD)and Thymidylate synthase(TS)for Predicting the Prognosis and Therapeutic Effects of Doxifluridine, An Intermediate form of Capecitabine, in adjuvant therapy for postoperative Node positive colorectal cancer(DukesC); Findings from a multicenter Phase2 trial.

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studiedDukes'C colorectal cancer which is removed curatively and surgically
Date of first enrollment2001/11/01
Target sample size300
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)chemotherapy(Doxifluridine:5'-DFUR)

Outcome(s)

Primary OutcomeDisease-free survival
Secondary OutcomeOverall survival

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criteriaappendiceal carcinoma and anal canal carcinoma of anal gland origin Multiple cancer patients except m cancer apparent infection sever postoperative complications active peptic ulcer Cardiac infarction within three months-uncontrolled hypertension -diabetes mellitus, uncontrolled or controlled with insulin -unstable angina, myocardial infarction needed to treat or febrile neutropenia

Related Information

Contact

public contact
Name Hirofumi Yamamoto
Address 2-2 Yamadaoka Suita-City Osaka Japan
Telephone 06-6879-3251
E-mail hyamamoto@gesurg.med.osaka-u.ac.jp
Affiliation Multicenter Clinical Study Group of Osaka,Colorectal Cancer Treatment Group Coordinating Office
scientific contact
Name Morito Monden
Address 2-2 Yamadaoka Suita-City Osaka Japan
Telephone 0668793251
E-mail hyamamoto@gesurg.med.osaka-u.ac.jp
Affiliation Osaka University Graduate School of Midicine Department of Surgery And Clinical Oncology